The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Arthritis Research & Therapy2010Vol. 12(2), pp. R63–R63
Citations Over TimeTop 1% of 2010 papers
Michael A. Becker, H. Ralph Schumacher, Luis R. Espinoza, Alvin F. Wells, Patricia MacDonald, Eric Lloyd, Christopher Lademacher
Abstract
NCT00430248.
Related Papers
- Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid.(2012)
- → Febuxostat Efficacy in Allopurinol-Resistant Tophaceous Gout(2011)4 cited
- → Risk of Severe Adverse Reactions Related to Allopurinol and Febuxostat in Asians(2018)2 cited
- [Life-threatening hyperuricemia during cytostatic leukemia therapy].(1982)
- → Comparative Study of Allopurinol and Uralyt-4 in patients with Hyperuricemia in Diyala Governorate.(2014)